Details der Publikation - Efficacy of dexamethasone for treatment of patients affected by COVID-19 with Acute Respiratory Distress Syndrome

Efficacy of dexamethasone for treatment of patients affected by COVID-19 with Acute Respiratory Distress Syndrome : A comparative, randomised controlled trial for evaluating the efficacy of dexamethasone administration in the treatment of patients affected by COVID-19 with Acute Respiratory Distress Syndrome - DEXA-COVID19

Medienart:	Klinische Studie

Erscheinungsjahr:	2020
Erschienen:	2020

Enthalten in:	WHO International Clinical Trials Registry Platform - (2020) vom: 20. Apr. Zur Gesamtaufnahme - year:2020

Sprache:	Englisch

Links:	Volltext [kostenfrei]

Themen:	610 Medical Condition: Acute respiratory distress syndrome (ARDS) in patients affected by COVID-19 MedDRA version: 21.1Level: PTClassification code 10001052Term: Acute respiratory distress syndromeSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] Phase: Phase 4 Recruitment Status: Authorised-recruitment may be ongoing or finished Study Type: Interventional

Anmerkungen:	WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 01-04-2020, Last updated: 2022-11-24

ICTRP ID:	EUCTR2020-001278-31-ES DEXA-COVID19

Förderinstitution / Projekttitel:

PPN (Katalog-ID):	WHO007310269

Internformat


LEADER	01000caa a22002652 4500
001	WHO007310269
003	DE-627
005	20230425181449.0
007	cr uuu---uuuuu
008	210507s2020 xx \|\|\|\|\|o 00\| \|\|eng c
035			\|a (DE-627)WHO007310269
035			\|a (UBBS_Klinische_Studien_WHO)EUCTR2020-001278-31-ES
035			\|a (UBBS_Klinische_Studien_WHO)DEXA-COVID19
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Efficacy of dexamethasone for treatment of patients affected by COVID-19 with Acute Respiratory Distress Syndrome \|b A comparative, randomised controlled trial for evaluating the efficacy of dexamethasone administration in the treatment of patients affected by COVID-19 with Acute Respiratory Distress Syndrome - DEXA-COVID19
264		1	\|c 2020
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 01-04-2020, Last updated: 2022-11-24
650		4	\|a Medical Condition: Acute respiratory distress syndrome (ARDS) in patients affected by COVID-19 MedDRA version: 21.1Level: PTClassification code 10001052Term: Acute respiratory distress syndromeSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
650		4	\|a Study Type: Interventional
650		4	\|a Phase: Phase 4
650		4	\|a Recruitment Status: Authorised-recruitment may be ongoing or finished
650		4	\|a 610
773	0	8	\|i Enthalten in \|t WHO International Clinical Trials Registry Platform \|g (2020) vom: 20. Apr.
773	1	8	\|g year:2020 \|g day:20 \|g month:04
856	4	0	\|u https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001278-31 \|z kostenfrei \|3 Volltext
912			\|a GBV_CTG
912			\|a SSG-OLC-PHA
951			\|a AR
952			\|j 2020 \|b 20 \|c 04

Zugang & Verfügbarkeit

Zugehörige Publikationen/Bände